Company News 

Scapa slumps on weak markets and slow cost cuts

Scapa slumps on weak markets and slow cost cuts

Scapa (SCPA) now expects its full-year trading profit to sit around £28m, below previous consensus forecasts of approximately £34m. The adhesive products specialist will fail to match expectations for its industrial turnover, while it is also making slower-than-expected progress on cutting costs in its healthcare arm.

To continue reading, subscribe today

and enjoy unlimited access to the following:

  • Tips of the Week
  • Funds coverage
  • Weekly features on big investment themes
  • Trading ideas
  • Comprehensive companies coverage
  • Economic analysis
Subscribe
Subscribe to Investors Chronicle

Related topics

Subscribe today

Full access for just £3.37 a week:

• Tips and recommendations - to beat the market 
• Portfolio clinic & Mr Bearbull - build a well-planned portfolio 
• Expert tools - track and manage investments effortlessly
• Plus free delivery to your home or office

Subscribe Now